期刊文献+

重视儿童及青少年糖尿病患者胰岛素的规范应用 被引量:3

Optimizing insulin therapy in children and adolescents with diabetes mellitus
原文传递
导出
摘要 糖尿病是一种因胰岛素分泌和(或)胰岛素作用发生缺陷导致胰岛素分泌绝对或相对不足,从而出现以慢性高血糖为特征的内分泌疾病.儿童和青少年中以1型糖尿病最为多见,而胰岛素治疗则是一种非常有效和必不可少的血糖调控手段.ISPAD早在1995年和2000年发布了第一版和第二版儿童及青少年1型糖尿病诊疗指南,指南开始强调胰岛素强化治疗的合理性和必要性.
作者 罗小平 吴薇
出处 《中华儿科杂志》 CAS CSCD 北大核心 2010年第6期409-412,共4页 Chinese Journal of Pediatrics
  • 相关文献

参考文献17

  • 1Heller SR,Colagiuri S,Vaaler S,et al.Hypoglycaemia with insulin aspart:a double-blind,randomised,crossover trial in subjects with Type 1 diabetes.Diubet Med,2004,21:769-775.
  • 2Danne T,Aman J,Schober E,et al.A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes.Diabetes Care,2003,26:2359-2364.
  • 3Danne T,Becker RH,Heise T,et al.Pharmacokinetics,prandial glucose control,and safety of insulin glulisine in children and adolescents with type 1 diabetes.Diabetes Care,2005,28:2100-2105.
  • 4Heise T,Pieber TR.Towards peakless,reproducible and long-acting insulin.An assessment of the basal analogues based on isoglycaemic clamp studies.Diabetes Ohes Metab,2007,9:648-659.
  • 5Robertson KJ,Schoenle E,Gucev Z,et al.Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.Diabet Med,2007,24:27-34.
  • 6Thisted H,Johnsen SP,Rungby J.An update on the long-acting insulin analog glargine.Basic Clin Pharmacol Toxicol,2006,99:1-11.
  • 7Danne T,Lüpke K,Walte K,et al.Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children,adolescents,and adults with type 1 diabetes.Diabetes Care,2003,26:3087-3092.
  • 8Danne T,Datz N,Endahl L,et al.Insulin detemir is characterized by a more reproducible pharmacokinetie profile than insulin glargine in children and adolescents with type 1 diabetes:results from a randomized,double-blind,controlled trial.Pediatr Diabetes,2008,9:554-560.
  • 9Hemkens LG,Grouven U,Bender R,et al.Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues:a cohort study.Diabetolagia,2009,52:1732-1744.
  • 10Currie CJ,Poole CD,Gale EA.The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.Diabetologia,2009,52:1766-1777.

同被引文献21

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部